Koers Port Erin Biopharma Investments Ltd London S.E.
Aandelen
IM00B6QH1J21
Beleggingsbeheer & Fondsbeheerders
Omzet 2022 | 6,42 mln. 8,1 mln. 7,48 mln. | Omzet 2023 | 29,7 mln. 37,47 mln. 34,6 mln. | Marktkapitalisatie | 104 mln. 131 mln. 121 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 8 mln. 10,09 mln. 9,32 mln. | Nettowinst (verlies) 2023 | 22 mln. 27,75 mln. 25,63 mln. | EV/omzet 2022 | 1,58 x |
Nettoliquiditeiten 2022 | 146 mln. 185 mln. 170 mln. | Nettoliquiditeiten 2023 | 170 mln. 214 mln. 198 mln. | EV/omzet 2023 | -2,23 x |
K/w-verhouding 2022 |
17,6
x | K/w-verhouding 2023 |
4,73
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 83,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Denham Eke
DFI | Director of Finance/CFO | 73 | 30-05-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jim Mellon
FOU | Founder | 68 | 03-05-11 |
Richard Reed
BRD | Director/Board Member | 51 | 31-05-19 |
David Giampaolo
BRD | Director/Board Member | 65 | 31-05-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,84% | 3,1 mld. | |
+31,41% | 2,06 mld. | |
+7,23% | 1,51 mld. | |
-11,54% | 1,19 mld. | |
+13,29% | 726 mln. | |
+10,70% | 674 mln. | |
+35,79% | 556 mln. | |
-4,17% | 500 mln. | |
+25,78% | 462 mln. |